Results 41 to 50 of about 71,233 (300)
Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy [PDF]
, 2017 Background: Chagas’ disease is an important cause of cardiomyopathy in Latin America. We aimed to compare clinical characteristics and outcomes in patients with heart failure (HF) with reduced ejection fraction caused by Chagas’ disease, with other ...
Claudio R. Gimpelewicz +17 more
core +3 more sources
Journal of the American College of Cardiology, 1997 Intravenous amiodarone was approved in 1995 for the treatment of malignant and resistant ventricular arrhythmia. Although it is an "old drug," much has been learned recently about this complex drug and its application in a variety of cardiac arrhythmias.
Kowey, Peter R +3 more
openaire +2 more sources
Management of amiodarone-related thyroid problems
Therapeutic Advances in Endocrinology and Metabolism, 2011 Amiodarone is a highly effective and well-established antiarrrhythmic drug. It can be used to treat supraventricular and ventricular tachyarrhythmias and has the added advantage of being well tolerated in patients with impaired left ventricular systolic ...
Shashithej K. Narayana +2 more
doaj +1 more source
Use of haloperidol in amiodarone induced delirium
Annals of Indian Psychiatry, 2022 Amiodarone, a versatile Class III antiarrhythmic drug, is considered one of the most effective agents in counteracting supraventricular and ventricular tachyarrhythmia.
Rachit Sharma +2 more
doaj +1 more source
Journal of Pharmaceutical Health Care and Sciences, 2021 Background Keeping the heart rate within the normal range has improved the survival of septic shock patients. Amiodarone could target the underlying pathophysiology of sepsis-induced tachycardia.
Masoud Khataminia +6 more
doaj +1 more source
Disfunção tiróidea e amiodarona [PDF]
, 2013 Although most patients remain clinically euthyroid, some develop amiodarone-induced hyperthyroidism (HPEAI) or hypothyroidism (HPOAI). The authors present a retrospective analysis of ten patients with amiodarone-induced thyroid dysfunction.
Carvalho, P +6 more
core +3 more sources
Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
BMC Anesthesiology, 2017 Background Ion channels play a crucial role in the development of ischemic brain injury. Recent studies have reported that the blockade of various types of ion channels improves outcomes in experimental stroke models.
Masakazu Kotoda +4 more
doaj +1 more source
Endokrynologia Polska, 2015 Amiodarone, a benzofuranic iodine-rich antiarrhythmic drug, causes thyroid dysfunction in 15-20% of cases. Amiodarone can cause both hypothyroidism (AIH, amiodarone-induced hypothyroidism) and thyrotoxicosis (AIT, amiodarone-induced thyrotoxicosis). AIH is treated by L-thyroxin replacement and does not need amiodarone discontinuation.
Luigi Bartalena +7 more
openaire +4 more sources
Journal of Pharmacological Sciences, 2005 Amiodarone, which is generally classified as class III antiarrhythmic drug in the Vaughan Williams classification, is widely used for the treatments of refractory arrhythmias.
Yoshinobu Nagasawa +2 more
doaj +1 more source
Fetal tachycardia: A role for amiodarone as first- or second-line therapy? [PDF]
, 2008 SummaryBackgroundFetal tachycardias result in serious prenatal and postnatal morbidity and mortality. Intrauterine treatment can improve prognosis dramatically and the therapeutic protocol is well defined.
Pézard, Philippe Georges +7 more
core +4 more sources